Pharming Group (PHAR)
(Delayed Data from NSDQ)
$8.00 USD
+0.58 (7.82%)
Updated Aug 14, 2024 02:22 PM ET
4-Sell of 5 4
C Value F Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 10/24/24 |
---|---|
Current Quarter | 0.01 |
EPS Last Quarter | -0.01 |
Last EPS Surprise | NA |
ABR | 1.25 |
Earnings ESP
|
2,100.00% |
---|---|
Current Year | -0.03 |
Next Year | 0.22 |
EPS (TTM) | -0.18 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 76.93M | 83.77M | 288.71M | 328.17M |
# of Estimates | 2 | 2 | 3 | 3 |
High Estimate | 78.00M | 89.34M | 297.03M | 339.80M |
Low Estimate | 75.86M | 78.19M | 283.70M | 321.10M |
Year ago Sales | 66.66M | 81.20M | 245.30M | 288.71M |
Year over Year Growth Est. | 15.41% | 3.16% | 17.70% | 13.67% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.01 | 0.06 | -0.03 | 0.22 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | 0.11 | 0.11 | 0.00 | 0.65 |
High Estimate | 0.11 | 0.11 | 0.20 | 0.65 |
Low Estimate | -0.10 | 0.00 | -0.30 | -0.40 |
Year ago EPS | 0.05 | -0.03 | -0.14 | -0.03 |
Year over Year Growth Est. | -80.00% | 300.00% | 78.57% | 833.34% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 2 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.01 | 0.06 | -0.03 | 0.22 |
7 Days Ago | 0.01 | 0.06 | -0.03 | 0.22 |
30 Days Ago | 0.00 | 0.00 | -0.03 | 0.20 |
60 Days Ago | 0.10 | 0.10 | 0.20 | 0.55 |
90 Days Ago | 0.00 | 0.00 | -0.03 | 0.20 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.11 | 0.06 | -0.15 | 0.13 |
Zacks Consensus Estimate | 0.01 | 0.06 | -0.03 | 0.22 |
Earnings ESP | 2,100.00% | 0.00% | -350.01% | -42.31% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.01 | -0.19 | -0.03 | 0.05 | NA |
Estimate | 0.00 | 0.01 | 0.05 | 0.13 | NA |
Difference | -0.01 | -0.20 | -0.08 | -0.08 | -0.09 |
Surprise | NA | -2,000.00% | -160.00% | -61.54% | -740.51% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more